1. Home
  2. NRXP vs PYN Comparison

NRXP vs PYN Comparison

Compare NRXP & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • PYN
  • Stock Information
  • Founded
  • NRXP 2015
  • PYN 2002
  • Country
  • NRXP United States
  • PYN United States
  • Employees
  • NRXP N/A
  • PYN N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • PYN Investment Managers
  • Sector
  • NRXP Health Care
  • PYN Finance
  • Exchange
  • NRXP Nasdaq
  • PYN Nasdaq
  • Market Cap
  • NRXP 32.6M
  • PYN 30.1M
  • IPO Year
  • NRXP N/A
  • PYN N/A
  • Fundamental
  • Price
  • NRXP $3.05
  • PYN $5.26
  • Analyst Decision
  • NRXP Strong Buy
  • PYN
  • Analyst Count
  • NRXP 4
  • PYN 0
  • Target Price
  • NRXP $28.50
  • PYN N/A
  • AVG Volume (30 Days)
  • NRXP 193.0K
  • PYN 19.9K
  • Earning Date
  • NRXP 08-13-2025
  • PYN 01-01-0001
  • Dividend Yield
  • NRXP N/A
  • PYN 5.07%
  • EPS Growth
  • NRXP N/A
  • PYN N/A
  • EPS
  • NRXP N/A
  • PYN N/A
  • Revenue
  • NRXP N/A
  • PYN N/A
  • Revenue This Year
  • NRXP N/A
  • PYN N/A
  • Revenue Next Year
  • NRXP N/A
  • PYN N/A
  • P/E Ratio
  • NRXP N/A
  • PYN N/A
  • Revenue Growth
  • NRXP N/A
  • PYN N/A
  • 52 Week Low
  • NRXP $1.10
  • PYN $4.84
  • 52 Week High
  • NRXP $6.01
  • PYN $6.60
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 44.37
  • PYN 41.82
  • Support Level
  • NRXP $3.03
  • PYN $5.25
  • Resistance Level
  • NRXP $3.53
  • PYN $5.37
  • Average True Range (ATR)
  • NRXP 0.17
  • PYN 0.10
  • MACD
  • NRXP -0.06
  • PYN -0.00
  • Stochastic Oscillator
  • NRXP 4.95
  • PYN 1.81

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest

PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.

Share on Social Networks: